Through tech-powered biopharma
Together, we can be the next stage in developing a revolutionary approach to drug discovery. We give communities the opportunity to invest in their own health as we improve how drugs are discovered to make them more effective and affordable.
With over 22 years of industry business and research experience, Dr. Urban A. Kiernan is the Founder, Chairman and CEO of iMetabolic Biopharma Corporation (iMBP).
He is a seasoned BioTech leader with decades of industry business and scientific research experience. However, his passion is what drives him beyond what any academic or work experience could ever afford him.
Urban, together with an amazing team of experts, are continuously working on the innovative iPlatform™ biotechnology.
Dr. Urban A. Kiernan
We are proud to support our crowdfunding Reg CF Offering through StartEngine, making investing an efficient and easy process. Here are some iMBP highlights:
• A founder with 22 years of combined industry business and research experience
• U.S. Patent for proprietary therapeutic methodology (US/9,783,600)
• IP provisional filing for iPlatform on January 14th, 2023
• 5 established disease therapeutic asset programs
• 4 additional programs in preparation to go online
• Minimum investment of $250
Our patent-pending technology-powered iPlatform removes roadblocks that make drug development slow, expensive,
Our computational approach uses in-silico therapeutic discovery and molecular design to improve traditional biotechnology, creating economic & time-saving advantages to drug discovery. This is the value that TechBio offers to you and your loved ones.
Our revolutionary approach landed us key strategic partnerships, including Amazon Web Services, Ligand Pharmaceuticals,
iMBP is also proud to be part of the McDermott Wills and Emory LEAP program for corporate legal counsel.
Together, with a group of experienced advisors and executive team, our future has never been brighter.
BioTech investment opportunities are reserved for an elite circle of the same investors. We are eager to break this cycle by sharing our unique equity crowdfunding campaign with YOU.
Give communities the opportunity to directly invest in solutions for their own health. Won’t you join us in transforming the way drugs are developed?